AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

JOHNSON & JOHNSON Director's Dealing 2023

Apr 13, 2023

29750_dirs_2023-04-13_3626e544-c23f-462e-916b-39e03186f480.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2023-04-03

Reporting Person: REED JOHN C (EVP, Pharmaceuticals R&D)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	306.0000	Direct